Publications
Recent Presentations
Biomarck Pharmaceuticals, Ltd., a clinical-stage biopharmaceutical company focused on developing peptides that inhibit MARCKS to…
BiomarckMay 26, 2021
Biomarck Pharmaceuticals, Ltd., a clinical-stage biopharmaceutical company focused on developing peptides that inhibit MARCKS to…
InvestorsMay 12, 2021
Featured Manuscripts
Biomarck is proud to share selected publications which highlight key data or discussions relevant to our development programs and platform technology.
Sheats MK, Yin Q, Fang S, et al. Marcks and lung disease. Am J Respir Cell Mol Biol. 2019;60(1):16-27.
ARDS, Cancer
Yin Q, Fang S, Park J, Crews AL, Parikh I, Adler KB. An inhaled inhibitor of myristoylated alanine-rich c kinase substrate reverses lps-induced acute lung injury in mice. Am J Respir Cell Mol Biol. 2016;55(5):617-622.
ARDS
Chen C-H, Thai P, Yoneda K, Adler KB, Yang P-C, Wu R. A peptide that inhibits function of Myristoylated Alanine-Rich C Kinase Substrate (Marcks) reduces lung cancer metastasis. Oncogene. 2014;33(28):3696-3706.
Cancer
Chen C-H, Chiu C-L, Adler KB, Wu R. A novel predictor of cancer malignancy: up-regulation of myristoylated alanine-rich C kinase substrate phosphorylation in lung cancer. Am J Respir Crit Care Med. 2014;189(8):1002-1004.
Cancer
Agrawal A, Murphy EC III, Park J, Adler KB, Parikh I. Aerosolized BIO-11006, a novel MARCKS-related peptide, improves airway obstruction in a mouse model of mucus hypersecretion. Journal of Epithelial Biology and Pharmacology. 3: 13-20; 2011.
COPD
Agrawal A, Rengarajan S, Adler KB, et al. Inhibition of mucin secretion with MARCKS-related peptide improves airway obstruction in a mouse model of asthma. J Appl Physiol (1985). 2007;102(1):399-405.
COPD
Park J-A, Adler KB. Potential therapy for mucus hypersecretion in chronic obstructive pulmonary disease. Journal of Organ Dysfunction. 2007;3(2):66-71.
COPD
Singer M, Martin LD, Vargaftig BB, et al. A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma. Nat Med. 2004;10(2):193-196.
COPD